Analysts/Institutional Investor Meet/Con. Call Updates

August 11, 2026 To, To, BSE Limited, Listing Department, 25, P. J. Towers, National Stock Exchange of India Ltd., Dalal Street, Exchange Plaza, Bandra Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai- 400051 R ef: Company Scrip Code: 532834 Ref: Symbol: CAMLINFINE || Series: EQ Sub: Audio recording of the conference call on the Un-audited Financial Results (Consolidated and Standalone) for the quarter ended June 30, 2026. In continuation of our disclosures dated August 4, 2026 and August 11, 2026 and pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), the audio recording of the conference call held today i.e. on Tuesday, August 11, 2026 on the Un-audited Financial Results (Consolidated and Standalone) for the quarter ended June 30, 2026 is available at the Company’s website at https://www.camlinfs.com/investor-relations/home/investor_call_recording. The Management was represented by Mr. Ashish Dandekar, Chairman & Managing Director, Mr. Nirmal Momaya, Managing Director and Mr. Santosh Parab, Chief Financial Officer. Discussions were based on publicly available information. No unpublished price sensitive information (UPSI) was discussed during the interactions. We request you to take the above on record and the same be treated as compliance under the applicable Regulations of SEBI Listing Regulations. Thanking You, For Camlin Fine Sciences Limited Rahul Sawale Company Secretary & VP Legal